A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85

著者: Jens Overgaard, Hanne Sand Hansen, Marie Overgaard, Lars Bastholt, Anne Berthelsen, Lena Specht, Birgit Lindeløv, Karsten Juhl Jørgensen - Radiotherapy and Oncology 1998 被引用: 567